Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 12584542)

Published in J Pediatr on February 01, 2003

Authors

Flavia Bortolotti1, Luigi Muratori, Paloma Jara, Loreto Hierro, Gabriella Verucchi, Raffaella Giacchino, Cristiana Barbera, Lucia Zancan, Maria Guido, Massimo Resti, Sabrina Pedditzi, Francesco Bianchi, Angelo Gatta

Author Affiliations

1: Department of Pediatrics, University of Padua, Padua, Italy.

Articles by these authors

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol (2003) 5.17

Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med (2014) 4.64

Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J Hepatol (2013) 4.24

How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol (2013) 3.75

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15

Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum (2005) 3.01

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol (2003) 2.69

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol (2006) 2.61

SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology (2009) 2.45

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS (2011) 2.45

Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol (2008) 2.14

Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation (2004) 2.04

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol (2010) 2.01

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis (2005) 1.83

A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology (2009) 1.78

Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. Blood (2002) 1.77

Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol (2008) 1.71

Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr (2003) 1.70

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68

Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis (2002) 1.68

Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis (2003) 1.65

Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol (2012) 1.65

Genotype-phenotype correlation in Italian children with Wilson's disease. J Hepatol (2008) 1.63

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl (2009) 1.60

Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One (2010) 1.59

Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. Gut (2010) 1.59

Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol (2007) 1.56

An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy. Pediatr Blood Cancer (2010) 1.55

Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. Liver Transpl (2007) 1.52

Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology (2008) 1.52

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients. Liver Int (2010) 1.51

Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl (2002) 1.50

Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol (2009) 1.48

Characteristics of minimal hepatic encephalopathy. Metab Brain Dis (2004) 1.47

A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology (2004) 1.47

Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46

Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver Transpl (2014) 1.46

Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus. Liver Transpl (2008) 1.46

Management of chronic hepatitis C in childhood: the impact of therapy in the clinical practice during the first 2 decades. Dig Liver Dis (2010) 1.42

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40

NOTCH2 mutations in Alagille syndrome. J Med Genet (2011) 1.40

Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40

Clinical and radiologic manifestations of congenital extrahepatic portosystemic shunts: a comprehensive review. Radiographics (2011) 1.37

Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology (2007) 1.34

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol (2007) 1.34

Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med (2008) 1.31

Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology (2006) 1.27

Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol (2007) 1.26

Myositis ossificans circumscripta: a paediatric case and review of the literature. Eur J Pediatr (2009) 1.25

Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24

Duodenal bulb biopsies in celiac disease: a multicenter study. J Pediatr Gastroenterol Nutr (2008) 1.24

Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol (2002) 1.23

Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine (2009) 1.23

Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis (2003) 1.18

Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology (2010) 1.14

Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum Mol Genet (2004) 1.13

Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J Hepatol (2005) 1.13

Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant (2005) 1.12

Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol (2003) 1.12

Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol (2003) 1.12

Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. Dig Liver Dis (2012) 1.10

A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10

Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg (2008) 1.10

Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? Eur J Cancer (2011) 1.10

Chronic hepatitis C virus infection in children. J Pediatr Gastroenterol Nutr (2010) 1.09

Autoimmune hepatitis. J Pediatr Gastroenterol Nutr (2009) 1.09

Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev (2008) 1.08

Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J (2008) 1.07

Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol (2006) 1.06